Sale!

Chimerism Split Cell Analysis – Myeloid Cell CD15 Test

Original price was: 2,080 د.إ.Current price is: 1,870 د.إ.

-10%

Chimerism Split Cell Analysis, specifically focusing on Myeloid Cell CD15 testing, is a specialized diagnostic procedure aimed at identifying the presence of two or more genetically distinct cell populations within an individual, often as a result of bone marrow or stem cell transplantation. This test is particularly critical in monitoring and assessing the success of transplant procedures, ensuring that the donor cells are effectively engrafting and replacing the recipient’s original cells.

The CD15 marker is predominantly found on the surface of myeloid cells, which include neutrophils, eosinophils, and monocytes – key components of the immune system. By analyzing these cells for chimerism, medical professionals can gain valuable insights into the patient’s post-transplant recovery process, including the detection of potential graft-versus-host disease (GVHD) or graft rejection early on.

Conducted at DNA Labs UAE, this test is meticulously designed to provide accurate and crucial information regarding the engraftment status and immune system health post-transplant. The cost of the Myeloid Cell CD15 Test is set at 1870 AED, reflecting the sophisticated nature of the analysis and the invaluable data it offers in guiding patient care and treatment plans.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CHIMERISM SPLIT CELL ANALYSIS – MYELOID CELL CD15 Test

Are you in need of a CHIMERISM SPLIT CELL ANALYSIS – MYELOID CELL CD15 Test in UAE? Look no further than DNA Labs UAE. We offer this test at a cost of AED 1870.0.

Test Details

The Chimerism Split Cell Analysis – Myeloid Cell (CD15) test is a laboratory test used to determine the percentage of donor and recipient cells in a patient who has undergone a hematopoietic stem cell transplant. During a stem cell transplant, healthy stem cells from a donor are infused into the patient’s bloodstream to replace damaged or diseased cells.

The Chimerism Split Cell Analysis – Myeloid Cell test specifically looks at the myeloid cells, which are a type of white blood cell that includes granulocytes, monocytes, and macrophages. The test involves separating the patient’s white blood cells into two populations: CD15 positive cells (myeloid cells) and CD15 negative cells (lymphoid cells). The CD15 positive cells are then further analyzed to determine the percentage of donor and recipient cells present. This analysis helps determine the level of engraftment, which is the successful establishment of the donor cells in the patient’s body.

The Chimerism Split Cell Analysis – Myeloid Cell (CD15) test is typically performed at regular intervals after a stem cell transplant to monitor the progress of engraftment and to detect any signs of graft rejection or relapse. The results of the test are reported as a percentage of donor cells in the myeloid cell population. A higher percentage of donor cells indicates a higher level of engraftment and a successful transplant.

Test Components and Price

Test Name: CHIMERISM SPLIT CELL ANALYSIS – MYELOID CELL CD15 Test

Components: PCR, STR / Fragment analysis

Price: 1870.0 AED

Sample Condition

Sample: 4 ml (2 ml min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube

Shipping: Ship refrigerated. DO NOT FREEZE.

Indicate Date of Bone Marrow Transplant.

Report Delivery

Sample: Daily by 11 am

Report: 7 Working days

Pre Test Information

Indicate Date of Bone Marrow Transplant.

Doctor and Test Department

Doctor: Oncologist

Test Department: Bone Marrow Transplantation

Test Name CHIMERISM SPLIT CELL ANALYSIS – MYELOID CELL CD15 Test
Components
Price 1870.0 AED
Sample Condition 4 ml (2 ml min.) whole blood \/ Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Indicate Date of Bone MarrowTransplant.
Report Delivery Sample Daily by 11 am; Report 7 Working days
Method PCR, STR / Fragment analysis
Test type Bone Marrow Transplantation
Doctor Oncologist
Test Department:
Pre Test Information Indicate Date of Bone MarrowTransplant.
Test Details

The Chimerism Split Cell Analysis – Myeloid Cell (CD15) test is a laboratory test used to determine the percentage of donor and recipient cells in a patient who has undergone a hematopoietic stem cell transplant.

During a stem cell transplant, healthy stem cells from a donor are infused into the patient’s bloodstream to replace damaged or diseased cells. The Chimerism Split Cell Analysis – Myeloid Cell test specifically looks at the myeloid cells, which are a type of white blood cell that includes granulocytes, monocytes, and macrophages.

The test involves separating the patient’s white blood cells into two populations: CD15 positive cells (myeloid cells) and CD15 negative cells (lymphoid cells). The CD15 positive cells are then further analyzed to determine the percentage of donor and recipient cells present. This analysis helps determine the level of engraftment, which is the successful establishment of the donor cells in the patient’s body.

The Chimerism Split Cell Analysis – Myeloid Cell (CD15) test is typically performed at regular intervals after a stem cell transplant to monitor the progress of engraftment and to detect any signs of graft rejection or relapse. The results of the test are reported as a percentage of donor cells in the myeloid cell population. A higher percentage of donor cells indicates a higher level of engraftment and a successful transplant.